These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7765107)

  • 1. The Super-Spinner: a low cost animal cell culture bioreactor for the CO2 incubator.
    Heidemann R; Riese U; Lütkemeyer D; Büntemeyer H; Lehmann J
    Cytotechnology; 1994; 14(1):1-9. PubMed ID: 7765107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of a bubble-swarm bioreactor for animal cell culture.
    Gudermann F; Lütkemeyer D; Lehmann J
    Cytotechnology; 1994; 15(1-3):301-9. PubMed ID: 7765944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A practical approach in bioreactor scale-up and process transfer using a combination of constant P/V and vvm as the criterion.
    Xu S; Hoshan L; Jiang R; Gupta B; Brodean E; O'Neill K; Seamans TC; Bowers J; Chen H
    Biotechnol Prog; 2017 Jul; 33(4):1146-1159. PubMed ID: 28440060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of monoclonal antibody in hollow fiber culture system with serum-free medium.
    Zhou W; Cai S
    Chin J Biotechnol; 1992; 8(1):41-9. PubMed ID: 1457721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Continuous production of anti-hepatitis B surface antigen monoclonal antibody in hollow fiber perfusion bioreactor].
    Meng MH; Chen GC; Hsieh JH; Yueh Y; Chen SC; Chang TH; Tsao D
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Aug; 21(3):125-40. PubMed ID: 3072154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-scale culture of hybridoma and mammalian cells in fluidized bed bioreactors.
    Dean RC; Karkare SB; Ray NG; Runstadler PW; Venkatasubramanian K
    Ann N Y Acad Sci; 1987; 506():129-46. PubMed ID: 3324851
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of aeration strategy on CHO cell performance during antibody production.
    Velez-Suberbie ML; Tarrant RD; Tait AS; Spencer DI; Bracewell DG
    Biotechnol Prog; 2013; 29(1):116-26. PubMed ID: 23074084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating cell specific oxygen uptake and carbon dioxide production rates for mammalian cells in perfusion culture.
    Goudar CT; Piret JM; Konstantinov KB
    Biotechnol Prog; 2011; 27(5):1347-57. PubMed ID: 21626724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Culture scale-up studies as seen from the viewpoint of oxygen supply and dissolved carbon dioxide stripping.
    Matsunaga N; Kano K; Maki Y; Dobashi T
    J Biosci Bioeng; 2009 Apr; 107(4):412-8. PubMed ID: 19332301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advancement in recombinant protein production using a marine oxygen carrier to enhance oxygen transfer in a CHO-S cell line.
    Le Pape F; Bossard M; Dutheil D; Rousselot M; Polard V; Férec C; Leize E; Delépine P; Zal F
    Artif Cells Nanomed Biotechnol; 2015 Jun; 43(3):186-95. PubMed ID: 25961365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A more efficient and economical approach for monoclonal antibody production.
    Ker-hwa Ou S; Patterson PH
    J Immunol Methods; 1997 Nov; 209(1):105-8. PubMed ID: 9448039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of culture environment for improved polyethylenimine-mediated transient production of recombinant monoclonal antibodies by CHO cells.
    Galbraith DJ; Tait AS; Racher AJ; Birch JR; James DC
    Biotechnol Prog; 2006; 22(3):753-62. PubMed ID: 16739959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and economic aspects of continuous mammalian cell culture.
    Werner RG; Walz F; Noé W; Konrad A
    J Biotechnol; 1992 Jan; 22(1-2):51-68. PubMed ID: 1367818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A sensitive monitoring system for mammalian cell cultivation processes: a PAT approach.
    Winckler S; Krueger R; Schnitzler T; Zang W; Fischer R; Biselli M
    Bioprocess Biosyst Eng; 2014 May; 37(5):901-12. PubMed ID: 24136042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A predictive high-throughput scale-down model of monoclonal antibody production in CHO cells.
    Legmann R; Schreyer HB; Combs RG; McCormick EL; Russo AP; Rodgers ST
    Biotechnol Bioeng; 2009 Dec; 104(6):1107-20. PubMed ID: 19623562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic comparison of diagnostic antibody production in perfusion stirred tank and in hollow fiber bioreactor processes.
    Vermasvuori R; Hurme M
    Biotechnol Prog; 2011; 27(6):1588-98. PubMed ID: 21954092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody production in hollow fiber bioreactors using serum-free medium.
    Heifetz AH; Braatz JA; Wolfe RA; Barry RM; Miller DA; Solomon BA
    Biotechniques; 1989 Feb; 7(2):192-9. PubMed ID: 2629847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of monoclonal antibodies by hybridoma cells in a flat sheet membrane bioreactor.
    Hagedorn J; Kargi F
    Biotechnol Prog; 1990; 6(3):220-4. PubMed ID: 1366615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An actively mixed mini-bioreactor for protein production from suspended animal cells.
    Diao J; Young L; Zhou P; Shuler ML
    Biotechnol Bioeng; 2008 May; 100(1):72-81. PubMed ID: 18078290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medium-scale production and purification of monoclonal antibodies in protein-free medium.
    Tarleton RL; Beyer AM
    Biotechniques; 1991 Nov; 11(5):590-3. PubMed ID: 1804247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.